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affected most population groups, regardless 
of age, race, and income or education level. 
Evidence from OECD countries indicates 
that obesity tends to be more common among 
individuals in disadvantaged socio-economic 
groups, particularly among women [3].
Numerous studies have shown an association 
between obesity, defined as a BMI over 30, 
and the appearance or exacerbation of a va-
riety of health problems including cardiovas-
cular diseases, diabetes, sleep apnea, some 
forms of cancer, depression and a general 
impairment of the quality of life [4-6]. Obese 
individuals have an elevated risk of death 
compared with normal weight individuals or 
INTRODUCTION
The prevalence of obesity is rising sharply. 
By 2008, 3.71 million Australians or 17.5 
percent of the population were estimated to 
be obese and three in five adults were either 
overweight or obese [1]. Rates were similar 
across Australian states but obesity was high-
er for males than females (18.5 versus 16.5 
percent respectively). The trend is expected 
to continue and to follow the US trend where, 
in 2011, obesity varied from a low of 20.1 
percent in Colorado to a high of 34.3 percent 
in West Virginia [2]. More generally, obesity 
rates in the western world have increased 
substantially over the past decade, and have 
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ABSTRACT
OBJECTIVES: The objective of this study was to describe and measure the loss of health related quality of life (HRQoL) 
associated with obesity using two generic instruments. The first of these, the SF-36, is the most widely used and validated 
HRQoL instrument worldwide. However, it does not provide utility weights and cannot be used to measure quality adjusted 
life years (QALYs), an increasingly common unit for comparing the effect of health states in economic evaluation studies. 
The second, the AQoL-8D, is a multi-attribute utility (MAU) instrument which was developed to increase sensitivity of 
previous MAU instruments to psycho-social dimensions of a health state and to allow the calculation of QALYs. Since 
the two instruments differ, an important additional objective of the study was to determine the validity of the AQoL-8D as 
judged by the SF-36, and therefore the confidence which might be placed upon its use in the context of obesity.
METHODS: Data were obtained from patients waiting for bariatric surgery who had completed both the SF-36 and AQoL-
8D quality of life instruments and a general questionnaire including height, weight, demographic and socio-economic 
information. For comparative purposes, scores were standardized using results from a representative sample of the general 
population. The content validity of the AQoL-8D was assessed by comparing it with the dimension scores from the SF-36 
and the summary component (physical and mental) scores. Overall scores from the SF-36 and AQoL-8D instruments were 
regressed upon patient BMI and the results from the AQoL-8D used to estimate the effect of overweight and obesity upon 
utility and lost QALYs.
RESULTS: The comparison of the instruments indicated that the AQoL-8D has good convergent, concurrent and content 
validity. Using both instruments, obesity was significantly associated with lower scores for 14 of their 16 dimensions. 
AQoL-8D, in particular, identified a significant decrease in psychological and social health with happiness, self-worth, 
coping and mental health, all being poorer than in the control group. Regression results implied that a change in BMI from 
30 to 50 decreases utility by 0.12 or by 13.8 percent of the average utility for a 25-35 year old.
CONCLUSION: AQoL-8D is a valid measure of utility in the context of obesity. Its inclusion of psycho-social effects 
significantly increases the measured adverse effects of obesity.
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those with a BMI between 18.5 and 25 [7]. 
As a consequence, weight related ill health 
and associated workforce absenteeism re-
sult in a high economic cost [8]. In the US 
9 percent of health expenditures are associ-
ated with obesity and overweight [9] and for 
Canada and the USA the annual economic 
cost, including excess mortality and disabili-
ty, has been estimated as $300 billion in 2009 
[10]. A review of European studies suggests 
a total economic burden ranging from 0.09% 
of GDP in France in 1992 to 0.6% in Ger-
many in 1990 and 0.6% in Greece in 2002 
[11]. The latter results are dated and the cost 
has undoubtedly risen with increasing rates 
of obesity in the past one and a half decades. 
A recent UK study estimates the cost of obe-
sity to the National Health Scheme and to the 
broader economy through lost productivity 
to be £4.2 and £15.8 billion respectively in 
2007 [12].
In Australia Colagiuri, Lee et al. [13] have es-
timated expenditures of $21 billion or 1.7% 
of GDP arising from overweight and obesity. 
This includes health care related costs and 
transfer payments arising from government 
pensions and other payments but does not 
include premature mortality or productiv-
ity losses. Excluding transfers, but including 
productivity, career and health-care costs, is 
an estimated cost to the economy of $8.3 bil-
lion [1]. However, these data only relate to 
a partial estimate of the weight related bur-
den of disease. They include a varying mix 
of costs, social transfers and the burden from 
premature mortality but omit the individual 
burden of a reduced quality of life (QoL). Re-
flecting measurement difficulties, there have 
been few attempts to quantify this in units 
which allow comparison with the burden of 
other health states.
Measuring health related 
quality of life (HRQoL)
Three types of questionnaire-based instru-
ment may be used to measure the effects of a 
health state upon QoL. First, disease-specific 
instruments have been designed to focus upon 
health states which are relevant for a partic-
ular disease (for reviews, see Bowling [14] 
and McDowell [15]). For example the Im-
pact of Weight on Quality of Life (IWQoL), 
was developed for use with individuals at 
all stages of obesity [16]. However, there is 
evidence to suggest that this instrument may 
be more relevant for morbidly obese indi-
viduals than for those with moderate obesity 
[17-19]. More generally, instruments in this 
first group are limited to the disease area for 
which they were designed and comparisons 
across disease groups are generally invalid.
This problem is overcome by use of a second, 
broad based generic, instrument such as the 
WHO Quality of Life (WHOQoL) scale [20], 
the Sickness Impact Profile [21] and the Not-
tingham Health Profile [22]. These were de-
signed to include the major elements and di-
mensions of the quality of life implying that in 
principle they satisfactorily measure the ma-
jority of health states. This facilitates compar-
ison and, additionally, increases the likelihood 
of detecting unexpected effects which may not 
be measured by a disease-specific instrument. 
The disadvantage of this second group of in-
struments is that the scores have no intrinsic 
meaning: they are index numbers which are 
difficult to integrate into an economic evalua-
tion study which compares costs and benefits 
or seeks to measure the burden of disease.
For these tasks economists have created a 
third measurement tool, the multi attribute 
utility (MAU) instrument. This is similar to 
a generic instrument as it is based upon a 
generic “descriptive system”, a set of items 
(questions and response categories) which 
describe the main dimensions and elements 
of the HRQoL. Their distinctive feature is 
that, additionally, they have a set of impor-
tance weights or a utility formula which re-
duces the responses to a single index of util-
ity. This measures the strength of preference 
for a health state. Generic non-utility instru-
ments may also be reduced to a single num-
ber but, by contrast with MAU instruments, 
this is obtained from unweighted responses; 
i.e. each response is given equal weighting 
and the final average score does not purport 
to have an independent meaning.
Utilities are measured on a (1.00-0.00) 
scale where 1.00 represents best health and 
0.00 represents death. The preference num-
ber (utility) on this scale therefore indicates 
the strength of preference for quality versus 
quantity of life. This permits the calculation 
of quality adjusted life years (QALYs) as the 
product of life years and the index number 
(for example, 10 years with a utility index of 
0.85 produces 8.5 QALYs). This is the unit 
of benefit used in cost utility analysis and, 
in principle, may be used to measure the 
HRQoL component of the burden of disease.
In practice both “generic” (i.e., unweighted 
generic) and MAU instruments differ in their 
construction and despite the claim that both 
are “generic” they contain different dimen-
sions and items and produce different scores. 
In the two major comparative studies of 
MAU instruments to date, an average of 44% 
and 53% of the variation in utility in the in-
struments was not explained by other MAU 
instruments, despite purporting to measure 
the same quantity (utility) and all being ad-
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ministered to the same individuals at the 
same point in time [23,24]. Consequently, 
good practice requires the validation of in-
struments in the different contexts in which 
they are to be used.
The objective of the present study was to 
describe the loss of HRQoL associated with 
obesity using both a generic and a MAU in-
strument. The generic instrument, the SF-36, 
is the most commonly used and validated of 
such instruments and has been widely used 
in the context of obesity [25]. The MAU in-
strument, the Assessment of Quality of Life 
(AQoL)-8D, produces utility scores which 
permit an estimate of the effect of obesity 
upon utility.
The AQoL-8D is a new instrument. Like the 
earlier AQoL instrument it was developed as 
a direct response to the problem of content 
invalidity of previous instruments, at least for 
some disease states. AQoL-8D is the largest 
MAU instrument to date, defining 2.4 x 1023 
health states. This does not ensure content 
validity but, in contrast to non-AQoL MAU 
instruments, it was constructed using psycho-
metric methods designed to achieve content 
validity [26]. Despite this, confidence in con-
tent validity must be evidence-based and test-
ing of the AQoL-8D to date has been limited 
[27]. A second focus of the present paper is 
therefore the empirical evidence relating to 
the validity of the AQoL-8D in the context 
of obesity using the SF-36 and self-reported 
health to test the instrument.
The study employed data from both the gen-
eral population and from obese patients on 
a waiting list for bariatric surgery. The data 
collection and their analysis are described 
in Section 2 which also describes and con-
trasts the two instruments. Results from the 
comparison of the instruments are presented 
in Section 3. In the discussion section the as-
sociation between BMI and utility measured 
using the AQoL-8D instrument is compared 
with the results found in previous studies.
DATA, INSTRUMENTS 
AND ANALYSES
Study population
The study employed a sample of 690 indi-
viduals, of whom 196 were obese with a 
BMI above 30 (“patients”); and 494 were 
members of the general public (“popula-
tion”). “Patients” were recruited from the 
Centre for Bariatric Surgery (CBS) in Mel-
bourne. Because of limited capacity for the 
procedure, there are long queues for bariatric 
surgery in Australia. Patients over 18 years 
of age on the waiting list were approached 
by their clinicians and invited to participate 
in the research. Data were collected through 
self-completion questionnaires. The compos-
ite questionnaire included the 35 items of the 
AQoL-8D, the 36 items of the SF-36, and 
demographic questions including patients’ 
height and weight and the existence of a co-
morbidity. Surveys were completed over the 
21 month period to December 2009.
AQoL-8D data for the “public” were obtained 
during the interviews which were conducted 
for the construction of the instrument. These 
were selected to match the age-gender-edu-
cation profile of the Australian population. 
Data were subsequently used to “standard-
ize” results from patients by expressing their 
AQoL-8D scores as a percent of the popula-
tion score. The SF-36 population norms for 
the Australian general public were obtained 
independently [28].
The instruments
The Short Form 36 (SF-36) was developed 
from the 245 items of the Rand Medical Out-
comes Study [29]. From the original 40 phys-
ical and mental concepts, 8 were selected us-
ing psychometric procedures [30]. Reliability 
has been established on numerous occasions 
and in numerous countries [31,32]. Validity 
and sensitivity have likewise been tested in 
numerous contexts and countries (for a re-
view see McDowell [15]). Use of the SF-36 
is described in its manual and explained on 
the SF-36 website (http://www.sf-36.org).
The AQoL-8D is the fourth, and most 
comprehensive, of the AQoL instruments at 
the Centre for Health Economics, Monash 
University. It was developed to achieve 
increased sensitivity in the psycho-social 
dimensions which have been relatively 
neglected in previous MAU instruments, 
including earlier versions of the AQoL. 
Like the SF-36 its descriptive system was 
derived from a large number (250) of items 
and reduced to 8 dimensions using structural 
equation modeling (SEM) and data from a 
survey of 712 patients and members of the 
public [26]. A second survey of 620 patients 
and the public obtained utility (time tradeoff) 
scores for key parameters which permitted 
the creation of a utility scoring formula 
[33]. Internal and test-retest reliability 
coefficients are high [34]. Validation tests 
have been limited. Results are summarized 
in Richardson and Khan [27]. Use of the 
instrument is explained on the AQoL website 
[http://www.aqol.com.au/]. The algorithms 
for converting item responses into instrument 
scores are given in Hays et al. [35].
The dimensions and items of the two instru-
ments are summarized in Table I. The eight 
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dimensions of SF-36 are grouped into two 
summary measures: the “physical compo-
nent summary” (PCS) and “mental compo-
nent summary” (MCS). The PCS consists of 
physical functioning (PF), role limit physical 
(RP), bodily pain (BP) and general health 
(GH). The MCS consists of vitality (VT), 
social functioning (SF), mental health (MH) 
and role limit emotional (RE). The AQoL-
8D dimensions are also summarized in two 
measures: the “physical super dimension” 
(PSD) and the “mental super dimension” 
(MSD). The PSD includes the dimensions 
of independent living (IL), senses (Sen) and 
pain (Pain); and the MSD includes happiness 
(Hap), coping (Cop), relationships (Rel), 
self-worth (SW) and mental health (MH).
The SF-36 has a greater emphasis upon phys-
ical dimensions, with walking and the ability 
to work having 5 and 4 items respectively. 
Dexterity is included in the SF-36 but ex-
cluded from the AQoL-8D. However, the SF-
36 includes no items relating directly to the 
physical senses or communication, whereas 
AQoL-8D has 3 and 1 items respectively re-
lating to these elements. AQoL-8D has a rela-
tively greater emphasis upon psychological 
and social dimensions with 5 and 4 items 
dedicated to the broad concept of depression/
anxiety and social relationships respectively. 
AQoL-8D, but not SF-36, includes items for 
self-esteem and intimacy/sexual relation-
ships. SF-36 has more items directly con-
cerned with emotion related vitality. The dif-
ferences between the instruments reflect the 
Instrument dimensions and items
SF-36 AQoL-8D 
Physical 
QoL
 • Physical functioning (PF), 10 items: vigorous activities, 
moderate activities, lifting, climbing several flights of 
stairs, climbing one flight of stairs, bending, walking more 
than 1 km, walking ½ a km, walking 100 m, bathing
 • Role limit physical (RP), 4 Items: time spent on work, 
accomplished, limited to work, difficulty of performing work
 • Bodily pain (BP), 2 items: the degree of pain, interference 
with normal work due to pain
 • General health (GH), 6 items: general health, health 
rating, get sick a little easier, healthy as anybody, get 
worse, excellent health
 • Independent living (IL), 4 items: household task, mobility 
outside the home, walking and self-care
 • Senses (Sen), 3 items: vision, hearing, communication
 • Pain (Pain), 3 items: experience of serious pain, the 
degree of pain, interference with usual activities caused 
by pain
Mental 
QoL
 • Vitality (VT), 4 items: full of life, energy, fell worn out, feel 
tired
 • Social functioning (SF), 2 items: interference with normal 
activities, interference with social activities
 • Role limit emotional (RE), 3 items: time spent on work, 
accomplished less than you like, didn’t work as carefully 
as usual
 • Mental health (MH), 5 items: nervous, felt down and 
nothing could cheer you up, felt calm, felt down, 
happiness
 • Happiness (Hap), 4 items: contentment, enthusiasm, 
degree of feeling happiness, pleasure
 • Coping (Cop), 3 items: energy, being in control, coping 
with problems
 • Relationships (Rel), 7 items: relationship with family 
and friends, social isolation, social exclusion, intimate 
relationship, family and community role
 • Self-Worth (SW), 3 items: feeling like a burden, 
worthlessness, confidence
 • Mental health (MH), 8 items: feelings of depression, 
trouble sleeping, feelings of anger, self harm, feeling 
despair, worry, sadness, tranquility/agitation
Table I. SF-36 and AQoL-8D Instrument dimensions and items
different psychometric analyses used in their 
development, referenced above.
Analysis
The comparison in Tabe I suggests a broad 
similarity between the content of the SF-36 
and AQoL-8D but this is potentially mislead-
ing. The content of items depends upon their 
construction and specific wording and these 
differ. Omitted or superficially under-repre-
sented concepts may be detected by items 
from another dimension. The final scores for 
the two instruments also depend upon the 
combination formula, the way in which in-
dividual item responses are scored and com-
bined.
Like other non-utility generic instruments 
the SF-36 combines unweighted item scores 
whose values depend only upon the response 
level. As noted, AQoL-8D combines items 
with an empirically derived formula, which 
gives values approximating utilities as derived 
by the time trade-off (TTO) technique [36]. 
While measurement units therefore differ, the 
two instrument scores would be expected to 
correlate if they were both sensitive to varia-
tion in the quality of life. This property is used 
in the following section to test the convergent 
validity of AQoL-8D – its positive correlation 
with independently validated measures. How-
ever, an overall correlation between the in-
struments is a weak test of content as it could 
occur when only a subset of the instrument 
dimensions correlated and the AQoL-8D was 
insensitive to other dimensions of the SF-36.
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28% were moderately obese. Only 11 percent 
were slightly obese and none fell in the nor-
mal weight range. The mean BMI was 43.3 
for men, 42.4 for women and 42.6 overall. 
Prior to undertaking any statistical analysis, 
the internal consistency of both instruments 
was tested using Cronbach’s Alpha [37]. The 
alpha coefficient of 0.870 for AQoL-8D and 
0.874 for SF-36 respectively suggest good 
internal consistency for both instruments.
SF36 vs. AQoL-8D
SF-36 responses were transformed from a 
(0.00-100) to a (0.00-1.00) scale for com-
parison with the AQoL-8D. The resulting 
frequency distributions of the two instru-
Instrument
Mean  
(0-1) 
scale
Standard 
error
Range
Interquartile 
range (IQR)
Coefficient 
of relative 
variation (CRV)
SF-36
Total 0.55 0.015 0.79 0.33 0.36
PCS* 0.40 0.007 0.54 0.14 0.22
MCS* 0.48 0.006 0.45 0.12 0.17
AQoL-8D
Total 0.69 0.013 0.78 0.28 0.27
PSD* 0.63 0.011 0.65 0.23 0.25
MSD* 0.31 0.012 0.84 0.27 0.55
Table II. Summary statistics for the two instruxments*. Population sample: 196 
patients (male 23%, female 77%). Age group in years: (%) 18-24 (6.6); 25-34 
(13.8); 35-44 (13.8); 45-54 (32.7); 55-64 (21.9); >65 (3.1). Socio Economic 
Status (SES): group 1: (lowest) 5.8%; group: 2 5.8%; group 3: 12.9%; group 4: 
25.8%; group 5: (highest) 49.7%
 MCS = mental component summary; MSD = mental super dimension; PSD = physical 
super dimension
* Note that the summary scores cannot be compared with each other since they reflect the 
number of items and scale units which differ 
 
Figure 1. Patient frequency by age and BMI group
A more exacting test of content validity was 
therefore carried out, namely a comparison of 
the overall AQoL-8D with each of the com-
ponent dimension scores for the SF-36. A 
failure of the instrument to correlate with any 
of the component dimensions would suggest 
insensitivity of the AQoL-8D to that dimen-
sion. A test of concurrent validity – the ability 
of an instrument to discriminate between dif-
ferent groups – was also conducted, namely, 
a comparison of patients by their self-report-
ed health. The test of concurrent validity was 
also applied to the comparator instrument, 
the SF-36.
Regression analyses were used to estimate 
the average incremental effect of BMI on 
QoL, i.e. the average change in the instru-
ment scores with a change in BMI. The 
AQoL-8D score was used to estimate the ef-
fect of obesity on an individual’s utility and 
the expected reduction in their QALYs.
RESULTS
A total of 196 obese patients completed the 
questionnaire. As it was administered by 
the hospital, it was perceived as a prerequi-
site for treatment and the response rate was 
100%. Reflecting the fact that patients were 
eligible for bariatric surgery they were atypi-
cal of the general population. The mean age 
was 45.7. Three quarters were female (77%) 
and only 20 percent were aged less than 34. 
One half (49.7%) were from the highest so-
cioeconomic group and only 5.8% from the 
lowest (see Table II). Figure 1 reports the 
patient frequency by BMI and age. The dis-
tribution is heavily skewed towards the right 
hand side: 61% were morbidly obese and 
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ment scores for patients are shown in Figure 
2. AQoL-8D exhibits a right hand skew re-
flecting the fact that it measures utilities (in 
the economist’s sense). This is a reflection of 
people’s reluctance to trade quality for quan-
tity of life, as described earlier, in the vicinity 
of normal health.
Summary patient statistics are reported in Ta-
bles II and III. Measurement units and content 
of the SF-36 and AQoL-8D differ, which re-
sults in different numerical values for the sam-
ple mean (0.55 vs. 0.69) and different inter-
quartile ranges, IQR (0.33 vs. 0.28). For 
comparative purposes the coefficients of rela-
tive variation (CRV) were calculated. These 
express the standard deviation as a percentage 
of the mean. From Table II the SF-36 displays 
more variation reflecting the skewed and trun-
cated distribution of utility shown in Figure 2. 
AQoL-8D has greater variation in the physical 
and mental super dimension scores which do 
not measure utilities. From Table III both SF-
36 and AQoL-8D identify significant differ-
ences in QoL by gender and age. Both physical 
summary measures (PCS, PSD) identify sig-
nificant differences by gender but not by age. 
The two mental summary measures (MCS, 
MSD) reveal significant differences by age but 
not by gender. Neither instrument detected dif-
ferences by the educational status of patients. 
Figure 2. Frequency distributions of patient QoL scores 
Attributes
SF-36 AQoL-8D 
PCS MCS SF36 PSD MSD AQoL-8D
Mean se p Mean se p Mean se p Mean se p Mean se p Mean se p
Gender
Male 0.43 0.013 0.01 0.49 0.01 0.126 0.62 0.03 0.02 0.67 0.024 0.02 0.35 0.026 0.096 0.74 0.03 0.049
Female 0.39 0.008 0.47 0.007 0.54 0.017 0.62 0.012 0.3 0.014 0.67 0.02
Age
< 35 0.4 0.014 0.98 0.45 0.013 0.004 0.49 0.03 0.02 0.67 0.025 0.24 0.25 0.028 0.005 0.63 0.03 0.04
35-54 0.4 0.01 0.48 0.008 0.56 0.02 0.62 0.015 0.3 0.016 0.68 0.02
> 55 0.4 0.017 0.51 0.012 0.61 0.03 0.62 0.022 0.37 0.024 0.74 0.03
Table III. Patient scores by age and gender
MCS = mental component summary; MSD = mental super dimension; PCS = physical component summary; PSD = physical super dimension
AQoL-8D\
SF-36
AQoL-8D SF-36
AQoL-8D Physical Mental SF-36 Physical
AQoL-8D 1
Physical (PSD) 0.728* 1
Mental (MSD) 0.904* 0.506* 1
SF-36 0.820* 0.634* 0.762* 1
Physical (PCS) 0.533* 0.681* 0.406* 0.702* 1
Mental (MCS) 0.661* 0.284* 0.677* 0.665* -0.021
 
Table IV. Correlation between patient SF-36, AQoL-8D and component summary 
scores
* Correlation is significant at the 1 % level (2-tailed)
Figure 3. (A). Geometric mean regression of SF-36 vs. AQoL-8D (Geometric Mean Regressions*): patient data. (B). Physical 
summary scores vs. SF-36 and AQoL-8D: Patient data. (C). Psycho-social component summary scores vs. SF-36 and AQoL-8D, 
patient data
*Geometric mean regressions are derived from the geometric mean of parameters from the regression of each variable on the other. Results are 
independent of the choice of dependent and independent variable and are appropriate when both variables are subject to independent erro.
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Summary patient statistics are reported in Ta-
bles II and III. Measurement units and content 
of the SF-36 and AQoL-8D differ, which re-
sults in different numerical values for the sam-
ple mean (0.55 vs. 0.69) and different inter-
quartile ranges, IQR (0.33 vs. 0.28). For 
comparative purposes the coefficients of rela-
tive variation (CRV) were calculated. These 
express the standard deviation as a percentage 
of the mean. From Table II the SF-36 displays 
more variation reflecting the skewed and trun-
cated distribution of utility shown in Figure 2. 
AQoL-8D has greater variation in the physical 
and mental super dimension scores which do 
not measure utilities. From Table III both SF-
36 and AQoL-8D identify significant differ-
ences in QoL by gender and age. Both physical 
summary measures (PCS, PSD) identify sig-
nificant differences by gender but not by age. 
The two mental summary measures (MCS, 
MSD) reveal significant differences by age but 
not by gender. Neither instrument detected dif-
ferences by the educational status of patients. 
Figure 2. Frequency distributions of patient QoL scores 
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SF-36 AQoL-8D 
PCS MCS SF36 PSD MSD AQoL-8D
Mean se p Mean se p Mean se p Mean se p Mean se p Mean se p
Gender
Male 0.43 0.013 0.01 0.49 0.01 0.126 0.62 0.03 0.02 0.67 0.024 0.02 0.35 0.026 0.096 0.74 0.03 0.049
Female 0.39 0.008 0.47 0.007 0.54 0.017 0.62 0.012 0.3 0.014 0.67 0.02
Age
< 35 0.4 0.014 0.98 0.45 0.013 0.004 0.49 0.03 0.02 0.67 0.025 0.24 0.25 0.028 0.005 0.63 0.03 0.04
35-54 0.4 0.01 0.48 0.008 0.56 0.02 0.62 0.015 0.3 0.016 0.68 0.02
> 55 0.4 0.017 0.51 0.012 0.61 0.03 0.62 0.022 0.37 0.024 0.74 0.03
Table III. Patient scores by age and gender
MCS = mental component summary; MSD = mental super dimension; PCS = physical component summary; PSD = physical super dimension
AQoL-8D\
SF-36
AQoL-8D SF-36
AQoL-8D Physical Mental SF-36 Physical
AQoL-8D 1
Physical (PSD) 0.728* 1
Mental (MSD) 0.904* 0.506* 1
SF-36 0.820* 0.634* 0.762* 1
Physical (PCS) 0.533* 0.681* 0.406* 0.702* 1
Mental (MCS) 0.661* 0.284* 0.677* 0.665* -0.021
 
Table IV. Correlation between patient SF-36, AQoL-8D and component summary 
scores
* Correlation is significant at the 1 % level (2-tailed)
Figure 3. (A). Geometric mean regression of SF-36 vs. AQoL-8D (Geometric Mean Regressions*): patient data. (B). Physical 
summary scores vs. SF-36 and AQoL-8D: Patient data. (C). Psycho-social component summary scores vs. SF-36 and AQoL-8D, 
patient data
*Geometric mean regressions are derived from the geometric mean of parameters from the regression of each variable on the other. Results are 
independent of the choice of dependent and independent variable and are appropriate when both variables are subject to independent erro.
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tal health is greater than its correlation (0.66) 
with MCS one of its own components.
Evaluation studies typically use pooled or 
grouped results. To test the effect of this upon 
the overall correlation, data were pooled two 
ways. First, observations were ranked ac-
cording to their AQoL-8D score and divided 
into 20 equal sized groups. The correlation 
between pooled SF-36 and AQoL-8D scores 
rises to 0.96 (Figure 4). Secondly, data were 
pooled by patient BMI. In this case the cor-
relation was 0.69 (Figure 5).
Content validity
For the reasons outlined earlier, overall cor-
relation is a relatively weak test of validity, 
and the more demanding test of content va-
lidity is the correlation between the AQoL-
8D and the eight (independently validated) 
SF-36 dimension scores. Failure to correlate 
with any dimension would indicate insensi-
tivity with respect to this dimension of health. 
Test results are reported in Table V. The coef-
ficients vary from a low of 0.55 (role limit) to 
0.77 (mental health). As these represent cor-
relations between (non-utility) scores for par-
ticular dimensions of a health state and the 
total (utility) scores for complete health 
states, they are very high (see the average 
correlation of 0.66 and 0.73 between overall 
utilities in the two multi instrument compara-
tive studies cited above).
Concurrent validity
The high correlations shown in Figures 3A to 
3C imply that if the SF-36 has concurrent va-
lidity – the ability to discriminate between 
groups – then the AQoL-8D is likely to also 
display concurrent validity. A direct test of 
Figure 5. Comparison of patient mean SF-36 and AQoL-8D scores with BMI
Figure 4. Correlation between patient mean SF-36 scores and AQoL-8D utility scores
Physical  
dimensions
Mental  
dimensions
Physical function 0.62* Vitality 0.70*
Role limit 0.55* Role limit (emotion) 0.63*
Bodily pain 0.58* Mental health 0.77*
General health 0.60* Social functioning 0.73*
 
Table V. Content validity: correlation of patient AQoL-8D with SF-36 dimension 
scores
* Correlation is significant at the 1 % level (2-tailed)l
Convergent validity
Table IV reports correlation coefficients be-
tween the instruments and their summary 
component scores. Figure 3 displays the lin-
ear relationship between the chief aggregates 
estimated with geometric mean regression. 
These permit error terms in both variables 
and provide results which are independent of 
the choice of dependent variable. The overall 
correlation of 0.82 between AQoL-8D and 
SF-36 indicates a very close relationship be-
tween them. By comparison, in the two multi 
instrument comparisons of utility instruments 
cited earlier, the highest correlation found by 
the Australian study between any two MAU 
instruments was 0.80 (15D and AQoL-4D) 
and in the US study, the highest correlations 
were 0.72 between SF-6D and HUI 3 and 
0.82 between HUI 2 and HUI 3 [23,24]. Cor-
relations between the two physical and two 
mental summary scores are lower (0.681 and 
0.677 respectively) indicating that the instru-
ment content differs in the two domains but 
the correlations still exceed the average cor-
relation between utility instruments in the US 
study. The line of best fit between the SF-
36 and AQoL-8D shown in Figure 3A has a 
slope coefficient of 1.04 which indicates that 
changes in the SF-36 provide a close approx-
imation to changes in utility measured by the 
AQoL-8D.
The relationship between the overall physi-
cal and mental components of the two instru-
ments shown in Figures 3B and 3C provide 
tests of convergent validity (the extent to 
which the component scales correlate in the 
expected way) and a test of the sensitivity of 
the overall instrument scores to the compo-
nents. From Figure 3B the SF-36’s physical 
component summary score, PCS, has a rela-
tively low correlation with the overall AQoL-
8D (0.53), but only a correlation of 0.7 with 
the overall SF-36 of which it is a part. That 
is, the correlation with AQoL-8D is 0.53/0.70 
or 72% as large as the PCS correlation with 
the SF-36. From Figure 3C the SF-36 mental 
component summary score – MCS – has vir-
tually the same correlation with the overall 
AQoL-8D (0.66) as it does with the overall 
SF-36 (0.67). The correlation between the 
AQoL-8D mental summary score – MSD – 
and the overall SF-36 (0.76) is higher than 
for any other pairwise comparison except 
for the MSD with AQoL-8D itself. Surpris-
ingly, the SF-36 correlation of 0.76 with the 
MSD, the AQoL-8D summary score for men-
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this is reported in Figure 6. Patients were di-
vided into those reporting “very good” or 
“excellent”, “good”, “fair”, “poor” or “very 
poor” health. Concurrent validity implies that 
the instruments should detect differences be-
tween those categories. Scores for both the 
SF-36, AQoL-8D and their physical and 
mental summary component scores are 
shown in Figure 6 as histograms with their 
95% CI. The Figure displays the expected 
pattern. On this test the SF-36 has greater 
concurrent validity (F = 47.8, for the SF-36 
vs. F = 34.8, for the AQoL-8D). This is at-
tributable to greater discrimination by the 
PCS than the PSD. However the MSD has 
greater discriminatory power than MCS. 
Overall, however, both instruments perform 
well on this test.
Obesity and quality of life
Dimension effects
The effect of obesity upon HRQOL was ana-
lyzed by comparing the dimension and in-
strument scores of patients with the corre-
sponding scores for the population obtained 
Figure 6. Instrument scores by patient self-reported health
MCS = mental component summary; MSD = mental super dimension; PCS = physical component summary; PSD = physical super dimension
tal health is greater than its correlation (0.66) 
with MCS one of its own components.
Evaluation studies typically use pooled or 
grouped results. To test the effect of this upon 
the overall correlation, data were pooled two 
ways. First, observations were ranked ac-
cording to their AQoL-8D score and divided 
into 20 equal sized groups. The correlation 
between pooled SF-36 and AQoL-8D scores 
rises to 0.96 (Figure 4). Secondly, data were 
pooled by patient BMI. In this case the cor-
relation was 0.69 (Figure 5).
Content validity
For the reasons outlined earlier, overall cor-
relation is a relatively weak test of validity, 
and the more demanding test of content va-
lidity is the correlation between the AQoL-
8D and the eight (independently validated) 
SF-36 dimension scores. Failure to correlate 
with any dimension would indicate insensi-
tivity with respect to this dimension of health. 
Test results are reported in Table V. The coef-
ficients vary from a low of 0.55 (role limit) to 
0.77 (mental health). As these represent cor-
relations between (non-utility) scores for par-
ticular dimensions of a health state and the 
total (utility) scores for complete health 
states, they are very high (see the average 
correlation of 0.66 and 0.73 between overall 
utilities in the two multi instrument compara-
tive studies cited above).
Concurrent validity
The high correlations shown in Figures 3A to 
3C imply that if the SF-36 has concurrent va-
lidity – the ability to discriminate between 
groups – then the AQoL-8D is likely to also 
display concurrent validity. A direct test of 
Figure 5. Comparison of patient mean SF-36 and AQoL-8D scores with BMI
Figure 4. Correlation between patient mean SF-36 scores and AQoL-8D utility scores
Physical  
dimensions
Mental  
dimensions
Physical function 0.62* Vitality 0.70*
Role limit 0.55* Role limit (emotion) 0.63*
Bodily pain 0.58* Mental health 0.77*
General health 0.60* Social functioning 0.73*
 
Table V. Content validity: correlation of patient AQoL-8D with SF-36 dimension 
scores
* Correlation is significant at the 1 % level (2-tailed)l
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from the AQoL-8D and SF-36 norms data. 
Figure 7 presents the ratio of the scores for 
each of the 16 dimensions of the two instru-
ments and for the physical and mental sum-
mary component scores. The ratio represents 
an index of the patient score where the popu-
lation score is used as the norm. Consequent-
ly 1.00 would indicate a patient score equal 
to the population norm. A ratio less than 1.00 
indicates a poorer outcome. With the excep-
tion of the AQoL-8D dimensions for senses 
and relationships, each of the patient dimen-
sion scores is significantly less than the popu-
lation scores, i.e. the ratios are significantly 
less than unity. For the SF-36, the lowest rel-
ative dimension scores are for general health 
followed by vitality and physical function-
ing. For AQoL-8D the lowest relative scores 
are for independent living, pain and coping. 
Reflecting the emphasis in their construction, 
most of the decline in the SF-36 is attribut-
able to the physical dimensions (PCS of 0.8 
versus MCS of 0.95). In contrast, AQoL-8D 
physical and mental super-dimensions (PSD, 
MSD) scored 0.83 and 0.86 respectively.
BMI and QoL
The incremental change in instrument scores 
with an increase in BMI was analyzed using 
OLS linear regressions. These included BMI, 
patient age, gender and education as explana-
tory variables plus a single variable (illness) 
indicating whether a patient self-reported a 
“serious” illness. The analyses were carried 
out with the full dataset and separately for 
Figure 7. Comparison of patient and population standardized scores by dimension. Instrument and dimensions scores are 
standardized by dividing patient scores by the corresponding average scores for the control (population) groups
BP = bodily pain; Cop = coping; GH = general health; Hap = happiness; IL = independent living; MCS = mental component summary;  
MH = mental health; MSD = mental super dimension; PCS = physical component summary; PF = physical functioning; PSD = physical super 
dimension; Rel = relationships; RP = role limit physical; VT = vitality; RE = role limit emotional; Sen = senses; SF = social functioning; SW = self-worth
males and females. For comparative purpos-
es both the SF-36 and AQoL-8D scores were 
used as dependent variables.
Both the SF-36 and AQoL-8D were re-
gressed upon BMI and the other explanatory 
variables. Results are presented in Table VI. 
Regressions were very stable with little vari-
ation in the coefficients with the inclusion or 
exclusion of different variables. Patients 
with a self-reported serious illness had 
AQoL-8D scores which were, on average, 
0.059 lower than for other patients. Females 
had lower scores. Patients below age 35 and 
between 35 and 54 had average AQoL-8D 
scores 0.116 and 0.074 lower than others. 
These unexpected results may reflect a 
greater effect of obesity upon the psycho-
logical wellbeing of younger people. Results 
for the educational dummy variables were 
insignificant. The coefficient on BMI was 
-0.006 in all iterations of the model; that is, 
an increase in BMI of 10 is predicted to de-
crease the AQoL-8D utility score by 0.06. 
The incremental effect shown in Table 5 im-
plies that a change in BMI from 30 (slightly 
obese) to 50 (morbidly obese) decreases 
utility by 0.006 x 20 or by 0.12 which is 
0.12/0.87 or 13.8 percent of the average util-
ity score for a 25-34 year old. Since utility 
measures the preferred trade-off between 
quality and length of life this implies that an 
individual would accept a 13.8 percent re-
duction in their life expectancy to increase 
their QoL by the improvement predicted 
when BMI is reduced from 50 to 30.
Dependent
Independent 
AQoL-8D SF-36 
b t b t b t b t
BMI -0.006 -3.16*** -0.006 -3.39*** -0.005 -2.67 -0.005 -2.70***
Age 
 • <35 -0.116 -2.66*** -0.044 -0.108ns
 • 35-54 -0.074 -2.14** -0.058 1.51ns
Education
 • Trade 0.053 1.43ns 0.062 1.55ns
 • Degree 0.018 0.54ns 0.041 1.11ns
Illness -0.059 -2.04** -0.060 -1.88*
Female -0.072 -2.12** -0.085 -2.29**
Constant 0.941 1.083 0.79 0.85
R2 0.061 0.16 0.047 0.14
F 10.00 3.94 7.12 3.22
Table VI. Regressions: all respondents, patient AQoL-8D, SF-36
*** Significant at 1 percent level
** Significant at 5 percent level
* significant at 10 percent level
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Results for the SF-36 parallel the AQoL-8D 
results to a surprising extent (considering 
that AQoL-8D but not SF-36 scores include 
the utility weights ). Consistent with the lin-
ear relationship between AQoL-8D and SF-
36 displayed in Figure 4, the coefficient on 
BMI is almost identical with the coefficient 
for AQoL-8D. Signs on other variables are 
uniformly consistent but, with the exception 
of the dummy variable for females, insignifi-
cant. The overall explanatory power of the 
SF-36 model is lower.
DISCUSSION
The dual objectives of this paper were, firstly, 
to compare results from AQoL-8D and SF-
36 to determine whether the utilities derived 
from the former instrument were a valid rep-
resentation of the health related quality of life 
as measured by the latter instrument and, sec-
ondly, to use results from both instruments to 
describe and quantify the effects of obesity 
on QoL. The first set of results is therefore 
a test of the validity of the AQoL-8D. The 
latter results describe the impact of obesity 
upon the dimensions of health related wellbe-
ing and, using the AQoL-8D, the effect upon 
people’s health related utility.
Taking account of the differences in ques-
tions and differences in scoring, the similar-
ity in the results from the two instruments is 
striking. The frequency distributions of the 
overall scores differ reflecting the measure-
ment of utility by AQoL-8D and unweighted 
scores by the SF-36. Nevertheless the linear 
relationship between them (Figure 4) reveals 
an incremental change in AQoL-8D utilities 
which is virtually identical to the change in 
SF-36 scores and the correlation between 
them is very high. The important caveat is 
that these results were derived from patients 
waiting for bariatric surgery and could not 
be reliably extrapolated to other population 
groups.
Tests conducted in the first half of the paper 
indicate that the AQoL-8D has good conver-
gent and concurrent validity and, using the 
SF-36 as the criterion, good content validity. 
SF-36 scores varied more with self-reported 
health. However AQoL-8D was more closely 
related to BMI in the regression analyses. 
The AQoL-8D mental health super-dimen-
sion was more sensitive than its counterpart 
in the SF-36.
In the second half of the results, the instru-
ments identified a significant deterioration in 
the quality of life in every dimension of both 
instruments with only two exceptions. AQoL-
8D results identified a significant decrease in 
the psychological and social dimensions 
summarized by MSD. Happiness, self-worth, 
coping and mental health were all poorer and 
only social relationships were not affected.
BMI
Utility decrement from average utility for BMI = 20-25
HUI 3 EQ-5D SF-6D QWB SF-6D AQoL-8D*
25-29.9 -0.00 -0.013 -0.01 -0.014 -0.016 -0.0345
30.9-34.9 -0.02 -0.033 -0.06 -0.044 -0.030 -0.0645
> 35 -0.04 -0.073 -0.11 -0.052 -0.101
Table VII. Loss of utility with BMI, various studies. Sources: HUI 3 [38]; 
EQ-5D [39]; SF-6D [40]; QWB [41]; SF-6D [8]
* Present results
males and females. For comparative purpos-
es both the SF-36 and AQoL-8D scores were 
used as dependent variables.
Both the SF-36 and AQoL-8D were re-
gressed upon BMI and the other explanatory 
variables. Results are presented in Table VI. 
Regressions were very stable with little vari-
ation in the coefficients with the inclusion or 
exclusion of different variables. Patients 
with a self-reported serious illness had 
AQoL-8D scores which were, on average, 
0.059 lower than for other patients. Females 
had lower scores. Patients below age 35 and 
between 35 and 54 had average AQoL-8D 
scores 0.116 and 0.074 lower than others. 
These unexpected results may reflect a 
greater effect of obesity upon the psycho-
logical wellbeing of younger people. Results 
for the educational dummy variables were 
insignificant. The coefficient on BMI was 
-0.006 in all iterations of the model; that is, 
an increase in BMI of 10 is predicted to de-
crease the AQoL-8D utility score by 0.06. 
The incremental effect shown in Table 5 im-
plies that a change in BMI from 30 (slightly 
obese) to 50 (morbidly obese) decreases 
utility by 0.006 x 20 or by 0.12 which is 
0.12/0.87 or 13.8 percent of the average util-
ity score for a 25-34 year old. Since utility 
measures the preferred trade-off between 
quality and length of life this implies that an 
individual would accept a 13.8 percent re-
duction in their life expectancy to increase 
their QoL by the improvement predicted 
when BMI is reduced from 50 to 30.
Dependent
Independent 
AQoL-8D SF-36 
b t b t b t b t
BMI -0.006 -3.16*** -0.006 -3.39*** -0.005 -2.67 -0.005 -2.70***
Age 
 • <35 -0.116 -2.66*** -0.044 -0.108ns
 • 35-54 -0.074 -2.14** -0.058 1.51ns
Education
 • Trade 0.053 1.43ns 0.062 1.55ns
 • Degree 0.018 0.54ns 0.041 1.11ns
Illness -0.059 -2.04** -0.060 -1.88*
Female -0.072 -2.12** -0.085 -2.29**
Constant 0.941 1.083 0.79 0.85
R2 0.061 0.16 0.047 0.14
F 10.00 3.94 7.12 3.22
Table VI. Regressions: all respondents, patient AQoL-8D, SF-36
*** Significant at 1 percent level
** Significant at 5 percent level
* significant at 10 percent level
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in the absence of supporting evidence, it is 
not compelling.
CONCLUSION
The two instruments used in this study had 
16 dimensions describing the broad areas of 
health related mental and physical health. 
The “patients” included in the study revealed 
significantly lower scores on 14 of the 16 di-
mensions indicating that the effects of obesity 
are not confined to direct physical effects but 
include social and psychological problems.
An unusual feature of this study was the in-
clusion of an MAU instrument, the AQoL-
8D, which included these psycho-social fac-
tors and permitted the quantification of the 
effects of obesity upon “utility” as measured 
in economic evaluation studies. To obtain 
credible results the new instrument required 
validation and this was achieved by com-
parison with the SF-36. Results indicated a 
closer relationship between this non-utility 
instrument and the AQoL-8D utility instru-
ment than has been observed in the majority 
of studies comparing utility instruments. This 
justifies confidence in the results obtained by 
the AQoL-8D for economic evaluation.
Comparison of AQoL-8D scores with BMI 
suggest that, at least in the range of obser-
vations used in this study, there is a strong 
association between the two variables. The 
incremental effect of BMI is at least twice as 
great as obtained in previous studies, possi-
bly as a result of the inclusion of a broader 
range of psycho-social variables in the instru-
ment or high average BMI. If the relationship 
is causal, which is probable, then the loss of 
utility attributable to obesity implies that the 
health related burden of disease caused by 
the ongoing obesity epidemic is greater than 
previously believed which, in turn, increases 
the urgency for measures to combat it.
Regression analyses revealed very similar 
deterioration in the scores of both instru-
ments with BMI. The results from the AQoL-
8D regressions permit comparison with other 
studies which have employed MAU instru-
ments. These are summarized in Table VII. 
The striking feature in this comparison is 
that the effect of BMI identified by AQoL-
8D is approximately double the effect found 
in other studies. This is possibly attributable 
to the greater average BMI of patients in the 
present analyses, but may also be attributable 
to the wider scope of the AQoL-8D descrip-
tive system and, in particular, its sensitivity 
to psycho-social dimensions. These are of 
lesser importance in the other instruments in 
the comparison.
Comorbidities
An important caveat in the interpretation of 
these (and other) results is that the causal 
path in the association between obesity 
and quality of life cannot be demonstrated 
by the statistical association. In Kortt and 
Clarke [8] variables were included for the 
major diseases associated with overweight 
and obesity. In the present study a cruder, 
single self-reported variable was included 
for the existence of “serious” illness. The in-
clusion of these variables does not preclude 
the possibility that the loss of utility was 
causally related to other illnesses and not to 
BMI per se. However, if the causal path was 
from BMI to any disease to the loss of QoL 
then conclusions for the importance of BMI 
with respect to QoL need little qualification 
as the pathway does not alter the magnitude 
of the loss. In principle, it is possible that 
illnesses contracted independently of BMI 
result in obesity and that the former, not the 
latter, is the reason for decreasing utility. 
While this hypothesis cannot be disproven, 
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